Evaluation of alkylmaltosides as intestinal permeation enhancers: Comparison between rat intestinal mucosal sheets and Caco-2 monolayers

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 4, 2012, Pages 701-712

  Petersen, Signe Beck ^a,b   Nolan, Gavin ^a   Maher, Sam ^a   Rahbek, Ulrik Lytt ^b   Guldbrandt, Mette ^b   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Caco 2 monolayers; Dodecyl maltoside; Intestinal epithelia; Intestinal permeation enhancers; Oral peptide delivery; Tetradecyl maltoside

Indexed keywords

CARBON 14; DODECYL MALTOSIDE; MANNITOL; NONIONIC SURFACTANT; PENETRATION ENHANCING AGENT; TETRADECYL MALTOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL STRAIN CACO 2; COLON MUCOSA; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; ELECTRIC RESISTANCE; HISTOPATHOLOGY; INTESTINE MUCOSA; JEJUNUM MUCOSA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CACO-2 CELLS; CELL DEATH; CELL LINE, TUMOR; COLON; ELECTRIC IMPEDANCE; GLUCOSIDES; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MALTOSE; MANNITOL; MICELLES; PERMEABILITY; RATS; RATS, WISTAR; SURFACE-ACTIVE AGENTS;

EID: 84866523389     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.08.010     Document Type: Article

References (50)

1. F. Ahsan, J. Arnold, E. Meezan, and D.J. Pillion Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats Pharm. Res. 18 2001 1742 1746
2. F. Ahsan, J.J. Arnold, T. Yang, E. Meezan, E.M. Schwiebert, and D.J. Pillion Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-) Eur. J. Pharm. Sci. 20 2003 27 34
3. J.J. Arnold, F. Ahsan, E. Meezan, and D.J. Pillion Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells J. Pharm. Sci. 93 2004 2205 2213
4. J.J. Arnold, M.D. Fyrberg, E. Meezan, and D.J. Pillion Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-d-maltoside J. Pharm. Sci. 99 2010 1912 1920
5. P. Artursson Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
6. B.J. Aungst Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin Int. J. Pharm. 105 1994 219 225
7. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
8. B.J. Aungst Absorption enhancers: applications and advances AAPS J. 14 2012 10 18
9. M. Benincasa, A. Abalos, I. Oliveira, and A. Manresa Chemical structure, surface properties and biological activities of the biosurfactant produced by Pseudomonas aeruginosa LBI from soapstock Biomed. Life Sci. 85 2004 1 8
10. D.J. Brayden, V.A. Bzik, A.L. Lewis, and L. Illum CriticalSorb® promotes permeation of flux markers across isolated rat intestinal mucosae and caco-2 monolayers Pharm. Res. 64 2012 644 653
11. M.J. Cano-Cebrian, T. Zornoza, L. Granero, and A. Polache Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery Curr. Drug Deliv. 2 2005 9 22
12. X. Cao, L.X. Yu, C. Barbaciru, C.P. Landowski, H.C. Shin, S. Gibbs, H.A. Miller, G.L. Amidon, and D. Sun Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability Mol. Pharm. 2 2005 329 340
13. A.W. Cuthbert, and H.S. Margolius Kinins stimulate net chloride secretion by the rat colon Br. J. Pharmacol. 75 1982 587 598
14. A. D'Emanuele, R. Jevprasesphant, J. Penny, and D. Attwood The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability J. Control. Rel. 2004 447 453
15. A. Dube, J.A. Nicolazzo, and I. Larson Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate Eur. J. Pharm. Sci. 41 2010 219 225
16. J.G. Eley, and P. Triumalashetty In vitro assessment of alkylglycosides as permeability enhancers AAPS PharmSciTech 2 2001 E19
17. C.A. Ericsson, O. Soderman, V.M. Garamus, M. Bergstrom, and S. Ulvenlund Effects of temperature, salt, and deuterium oxide on the self-aggregation of alkylglycosides in dilute solution. 2. n- Tetradecyl-beta-d-maltoside Langmuir 21 2005 1507 1515
18. G. Fetih, S. Lindberg, K. Itoh, N. Okada, T. Fujita, F. Habib, P. Artersson, M. Attia, and A. Yamamoto Improvement of absorption enhancing effects of n-dodecyl-beta-d-maltopyranoside by its colon-specific delivery using chitosan capsules Int. J. Pharm. 293 2005 127 135
19. I. Hubatsch, E.G.E. Ragnarsson, and P. Arthursson Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers Nat. Protoc. 2 2007 2111 2119
20. A. Iida, M. Tomita, and M. Hayashi Regional differences in P-glycoproteon function in rat intestine Drug. Metab. Pharmacokinet. 20 2005 100 106
21. L. Illum Nasal drug delivery - recent developments and future prospects J. Control. Rel. 2012 (PMID 22300620)
22. W. Kamm, A. Jonczyk, T. Jung, G. Luckenbach, P. Raddatz, and T. Kissel Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2) Eur. J. Pharm. Sci. 10 2000 205 214
23. D.W. Lee, M.C. Leinung, and P. Grasso Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice. A study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administration Regul. Peptides 160 2010 129 132
24. E.T. Maggio Intravail: highly effective intranasal delivery of peptide and protein drugs Expert Opin. Drug Deliv. 3 2006 529 539
25. E.T. Maggio, and P. Grasso Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss Webster mice Regul. Peptides 167 2011 233 238
26. Maher, S., Brayden, D.J., 2012. Overcoming poor permeability: translating permeation enhancers for oral peptide delivery. Drug Disc. Today: Technol. DDDTEC-289 9, e-113-e119.
27. S. Maher, D.J. Brayden, L. Feighery, and S. McClean Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs Crit. Rev. Ther. Drug Carrier Syst. 25 2008 117 168
28. S. Maher, R. Kennelly, V.A. Bzik, A.W. Baird, X. Wang, D. Winter, and D.J. Brayden Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae Eur. J. Pharm. Sci. 38 2009 291 300
29. S. Maher, T.W. Leonard, J. Jacobsen, and D.J. Brayden Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic Adv. Drug Deliv. Rev. 61 2009 1427 1449
30. A. Makhlof, M. Werle, Y. Tozuka, and H. Takeuchi A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa J. Control. Rel. 149 2011 81 88
31. A. Maroni, L. Zema, M.D. Del Curto, A. Foppoli, and A. Gazzaniga Oral colon delivery of insulin with the aid of functional adjuvants Adv. Drug Deliv. Rev. 64 2012 540 556
32. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
33. M. Murakami, Y. Kusanoi, K. Takada, and S. Muranishi Assessment of enhancing ability of medium-chain alkyl saccharides as new absorption enhancers in rat rectum Int. J. Pharm. 79 1992 159 169
34. F. Mustafa, T. Yang, M.A. Khan, and F. Ahsan Chain length-dependent effects of alkylmaltosides on nasal absorption of enoxaparin J. Pharm. Sci. 93 2004 675 683
35. K. Nakamura, K. Takayama, T. Nagai, and Y. Maitani Regional intestinal absorption of FITC-dextran 4400 with nanoparticles based on beta-sitosterol beta-D-glucoside in rats J. Pharm. Sci. 92 2003 311 318
36. P. Nejdfors, Q. Wang, M. Ekelund, B.R. Weström, O. Jansson, C.L. Lindström, B. Karlsson, and B. Jeppsson Increased colonic permeability in patients with ulcerative colitis: an in vitro study Scand J. Gastroenterol. 33 1998 749 753
37. P.J. O'Brien, W. Irwin, D. Diaz, E. Howard-Cofield, C.M. Krejsa, M.R. Slaughter, B. Gao, N. Kaludercic, A. Angeline, P. Bernardi, P. Brain, and C. Hougham High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Archiv. Toxicol. 80 2006 580 604
38. D.J. Pillion, F. Ahsan, J.J. Arnold, B.M. Balusubramanian, O. Piraner, and E. Meezan Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption J. Pharm. Sci. 91 2002 1456 1462
39. B.I. Polentarutti, A.L. Peterson, A.K. Sjoberg, E.K. Anderberg, L.M. Utter, and A.L. Ungell Evaluation of viability of excised rat intestinal segments in the Ussing chamber: investigation of morphology, electrical parameters, and permeability characteristics Pharm. Res. 16 1999 446 454
40. L.A. Rawlinson, P.J. O'Brien, and D.J. Brayden High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures J. Control. Rel. 146 2010 84 92
41. R.B. Shah, A. Palamakula, and M.A. Khan Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin J. Pharm. Sci. 93 2004 1070 1082
42. Y. Tanaka, Y. Taki, T. Sakane, T. Nadai, H. Sezaki, and S. Yamashita Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum and colon Pharm. Res. 12 1995 523 528
43. K. Tsutsumi, S.K. Li, A.H. Ghanem, N.F.H. Ho, and W.I. Higuchi A systematic examination of the in vitro Ussing chamber and the in situ single-pass perfusion model systems in rat ileum permeation of model solutes J. Pharm. Sci. 92 2003 344 359
44. T. Uchiyama, T. Sugiyama, Y.S. Quan, A. Kotani, N. Okada, T. Fujita, S. Muranishi, and A. Yamamoto Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-d-maltopyranoside J. Pharm. Pharmacol. 51 1999 1241 1250
45. A.L. Ungell, S. Nylander, S. Bergstrand, A. Sjoberg, and H. Lennernas Membrane transport of drugs in different regions of the intestinal tract of the rat J. Pharm. Sci. 87 1998 360 366
46. C.S. Van, and W. Van Den Broeck Morphological and biochemical aspects of apoptosis, oncosis and necrosis Anat. Histol. Embryol. 31 2002 214 223
47. E.G. Walsh, B.E. Adamczyk, K.B. Chalasani, S. Maher, E.B. O'Toole, J.S. Fox, T.W. Leonard, and D.J. Brayden Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET®) Therapeut. Deliv. 2 2011 1595 1610
48. E.G. Walsh, S. Maher, M. Devocelle, P.J. O'Brien, A.W. Baird, and D.J. Brayden High content analysis to determine cytotoxicity of the antimicrobial peptide, melittin and selected structural analogs Peptides 32 2011 1764 1773
49. T. Yang, J.J. Arnold, and F. Ahsan Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin J. Drug Target 13 2005 29 38
50. D.Y. Yu, Q.L. Zhao, Z.L. Wei, T. Nomura, I. Kashiwakura, T.V. Kagiya, and T. Kondo Enhancement of radiation-induced apoptosis of human lymphoma U937 cells by sanazole Apoptosis 14 2009 655 664